JENNIFER OLSON: Open Payments
NPI 1780198317 · EAU CLAIRE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$546 in 23 payments from 15 companies in 2025. Trend: 2023 $952 · 2024 $485 · 2025 $546
Food & beverage: $546
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 1 | $134 |
| Novo Nordisk Inc | 4 | $69 |
| GENZYME CORPORATION | 2 | $48 |
| ABBVIE INC. | 2 | $44 |
| Regeneron Healthcare Solutions, Inc. | 2 | $43 |
| Lilly USA, LLC | 2 | $40 |
| PFIZER INC. | 2 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Exact Sciences Corporation | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
Products named: TREMFYA, DUPIXENT, Wegovy, OMVOH, LINZESS, Rybelsus, CAPLYTA, VRAYLAR.
Industry payments across WI — which companies pay providers there.
